Anti-BCMA Therapies Aim To Raise The Bar In Myeloma
ASCO Offers Stage For New Data For CAR-T And ADC Candidates
GSK’s antibody-drug conjugate may reach the market first, but CAR-T therapies from Bristol/bluebird and Janssen/Legend are close behind, and all three big pharmas have programs in earlier-stage disease.
